Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Barton

Showing results (101-110 of 332) with videos related to

Pageof 34
Sort By:
Expert Opinion on Drug Safety|January 19, 2020
Update on weight-gain caused by antipsychotics: a systematic review and meta-analysisBarbara B Barton, Felix Segger, Kai Fischer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 4, 2015
The population benefit of radiotherapy for cervical cancer: local control and survival estimates for optimally utilized radiotherapy and chemoradiationT P Hanna, J Shafiq, G P Delaney, et al.
European Journal of Cancer (Oxford, England : 1990)|June 17, 2009
Estimation of an optimal chemotherapy utilisation rate for colon cancer: an evidence-based benchmark for cancer careSusannah Jacob, Weng Ng, Ray Asghari, et al.
American Journal of Clinical Pathology|March 1, 1980
Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4). VI. Invasive papillary cancerE R Fisher, A S Palekar, C Redmond, et al.
Oecologia|December 23, 2016
Predator identity and time of day interact to shape the risk-reward trade-off for herbivorous coral reef fishesLaura B Catano, Mark B Barton, Kevin M Boswell, et al.
Lancet (London, England)|November 10, 1998
Fatality and interferon alpha for malignant melanomaJ J Carson, L H Gold, A B Barton, et al.
Acta Paediatrica (Oslo, Norway : 1992)|May 15, 2007
Seeing through the blind! Ability of hospital staff to differentiate morphine from placebo, in neonates at a placebo controlled trialLl Bergqvist, M Eriksson, Ss Kronsberg, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 29, 2010
Patterns of retreatment by radiotherapyM B Barton, H M Hudson, G Delaney, et al.
Clinical Colorectal Cancer|August 24, 2011
Chemotherapy in rectal cancer: variation in utilization and development of an evidence-based benchmark rate of optimal chemotherapy utilizationSusannah Jacob, Weng Ng, Ray Asghari, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 16, 2005
Technology enhancements and changes in radiotherapy throughput in New South WalesG P Delaney, R J Shafiq, B B Jalaludin, et al.
Pageof 34

Showing results (101-110 of 332) with videos related to

Sort By:
Pageof 34
Expert Opinion on Drug Safety|January 19, 2020
Update on weight-gain caused by antipsychotics: a systematic review and meta-analysisBarbara B Barton, Felix Segger, Kai Fischer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 4, 2015
The population benefit of radiotherapy for cervical cancer: local control and survival estimates for optimally utilized radiotherapy and chemoradiationT P Hanna, J Shafiq, G P Delaney, et al.
European Journal of Cancer (Oxford, England : 1990)|June 17, 2009
Estimation of an optimal chemotherapy utilisation rate for colon cancer: an evidence-based benchmark for cancer careSusannah Jacob, Weng Ng, Ray Asghari, et al.
American Journal of Clinical Pathology|March 1, 1980
Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4). VI. Invasive papillary cancerE R Fisher, A S Palekar, C Redmond, et al.
Oecologia|December 23, 2016
Predator identity and time of day interact to shape the risk-reward trade-off for herbivorous coral reef fishesLaura B Catano, Mark B Barton, Kevin M Boswell, et al.
Lancet (London, England)|November 10, 1998
Fatality and interferon alpha for malignant melanomaJ J Carson, L H Gold, A B Barton, et al.
Acta Paediatrica (Oslo, Norway : 1992)|May 15, 2007
Seeing through the blind! Ability of hospital staff to differentiate morphine from placebo, in neonates at a placebo controlled trialLl Bergqvist, M Eriksson, Ss Kronsberg, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 29, 2010
Patterns of retreatment by radiotherapyM B Barton, H M Hudson, G Delaney, et al.
Clinical Colorectal Cancer|August 24, 2011
Chemotherapy in rectal cancer: variation in utilization and development of an evidence-based benchmark rate of optimal chemotherapy utilizationSusannah Jacob, Weng Ng, Ray Asghari, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 16, 2005
Technology enhancements and changes in radiotherapy throughput in New South WalesG P Delaney, R J Shafiq, B B Jalaludin, et al.
Pageof 34